Fusion Antibodies (FAB) Stock Chart & Stock Price History GBX 14 0.00 (0.00%) As of 08/22/2025 11:50 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock Fusion Antibodies Stock Price Performance The Fusion Antibodies (FAB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 314.20%, with a year-to-date return of 95.53%. In the past month, the stock has increased 55.56%, reflecting recent market activity. As of the latest close, Fusion Antibodies traded at GBX 14 with a market cap of £13.17 million and volume of 1.89 million shares. Five years ago, the stock traded at GBX 92.50, representing a 84.86% decrease over that period. At the time, it had a market cap of £23.53 million and a volume of 1,088 shares. Receive FAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Fusion Antibodies and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-15.15%1 Month Performance+55.56%3 Month Performance+102.90%Year-To-Date Performance+95.53%1 Year Performance+314.20%5 Year Performance-84.86% FAB Stock Chart for Saturday, August, 23, 2025 FAB Chart by TradingView Fusion Antibodies Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/22/2025GBX 14.50GBX 14-3.45%GBX 15GBX 131.89 million shs£13.17 million08/21/2025GBX 14.32GBX 14.50+1.26%GBX 15.50GBX 13.251.70 million shs£13.64 million08/20/2025GBX 15.60GBX 14.32-8.21%GBX 15.50GBX 12.822.01 million shs£13.47 million08/19/2025GBX 16.50GBX 15.60-5.45%GBX 16.50GBX 14.511.45 million shs£14.67 million08/18/2025GBX 17.70GBX 16.50-6.78%GBX 18.15GBX 152.34 million shs£15.52 million08/15/2025GBX 16.83GBX 17.70+5.18%GBX 17.90GBX 15.761.87 million shs£16.65 million08/14/2025GBX 15.57GBX 16.83+8.09%GBX 17.50GBX 15.752.65 million shs£15.83 million08/13/2025GBX 14.90GBX 15.57+4.50%GBX 16.40GBX 14.681.45 million shs£14.64 million08/12/2025GBX 14.20GBX 14.90+4.93%GBX 16GBX 13.104.24 million shs£14.01 million08/11/2025GBX 14GBX 14.20+1.43%GBX 15GBX 12.117.78 million shs£13.36 million Get the Latest News and Ratings for FAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fusion Antibodies and its competitors with MarketBeat's FREE daily newsletter. 08/08/2025GBX 14GBX 14GBX 15.42GBX 146.27 million shs£13.17 million08/07/2025GBX 12.19GBX 14+14.85%GBX 14.77GBX 11.655.12 million shs£13.17 million08/06/2025GBX 11GBX 12.19+10.82%GBX 12.50GBX 10.503.42 million shs£11.47 million08/05/2025GBX 10.84GBX 11+1.48%GBX 12GBX 94.28 million shs£10.35 million08/04/2025GBX 11.32GBX 10.84-4.24%GBX 11.50GBX 10.222.31 million shs£10.20 million08/01/2025GBX 10.39GBX 11.32+8.97%GBX 11.50GBX 10.521.64 million shs£10.65 million07/31/2025GBX 10.85GBX 10.39-4.26%GBX 11GBX 101.05 million shs£9.77 million07/30/2025GBX 10.28GBX 10.85+5.60%GBX 11.50GBX 102.37 million shs£10.21 million07/29/2025GBX 10GBX 10.28+2.75%GBX 11GBX 9.503.03 million shs£9.66 million07/28/2025GBX 8.50GBX 10+17.65%GBX 10GBX 7.502.66 million shs£9.41 million07/25/2025GBX 9.02GBX 8.50-5.76%GBX 9GBX 8.111.58 million shs£8.00 million07/24/2025GBX 9GBX 9.02+0.22%GBX 9.50GBX 7.663.14 million shs£8.48 million07/23/2025GBX 7.96GBX 9+13.14%GBX 10.34GBX 7.504.56 million shs£8.47 million07/22/2025GBX 8.42GBX 7.96-5.52%GBX 8.50GBX 7.502.07 million shs£7.48 million Related Companies SkinBioTherapeutics Stock Price Chart Futura Medical Stock Price Chart Tissue Regenix Group Stock Price Chart Sareum Stock Price Chart Arecor Therapeutics Stock Price Chart Poolbeg Pharma Stock Price Chart Aptamer Group Stock Price Chart OptiBiotix Health Stock Price Chart IXICO Stock Price Chart Synairgen Stock Price Chart Receive FAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Fusion Antibodies and its competitors with MarketBeat's FREE daily newsletter. This page (LON:FAB) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fusion Antibodies plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Fusion Antibodies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access